RT @ONCOassist@twitter.com

A great end to #GI23 - great to see so many brilliant and passionate minds fighting GI cancers together!

Shout out to the top reached voices on Twitter: @marklewismd@twitter.com @pashtoonkasi@twitter.com @manjuggm@twitter.com @RenoHemonc@twitter.com @MPishvaian@twitter.com @CathyEngMD@twitter.com

#OncoAlert #OncTwitter

🐦🔗: https://twitter.com/ONCOassist/status/1617893186999029760

RT @DrSGraff@twitter.com

It’s almost that time! @OncoAlert@twitter.com #OncoAlertColloquium!
If you don’t want to miss any of the amazing talks, you can sign up HERE http://oncoalert360.com/the-oncoalert-colloquium-2022.html for a daily email bringing the magic to your inbox!
🪄📨 ➡️ 💻🍿
Thanks to the #OncoAlert team for the invite to present!

🐦🔗: https://twitter.com/DrSGraff/status/1616229867808235522

RT @OncoAlert@twitter.com

A Great DAY2⃣at #SABCS22 ‼️
Thank you @SABCSSanAntonio@twitter.com & Thanks Colleagues Worldwide🗺️

45.6M Impressions
6,5K Tweets
@OncoAlert@twitter.com 🚨faculty9⃣0⃣%of TOP🔟influences
3⃣of them Patient Advocates🙌

WE ARE ALL #Oncoalert 🌐
Best,
@weoncologists@twitter.com

🐦🔗: https://twitter.com/OncoAlert/status/1600872263170998273

RT @OncoAlert@twitter.com

A Great DAY2⃣at #SABCS22 ‼️
Thank you @SABCSSanAntonio@twitter.com & Thanks Colleagues Worldwide🗺️

45.6M Impressions
6,5K Tweets
@OncoAlert@twitter.com 🚨faculty9⃣0⃣%of TOP🔟influences
3⃣of them Patient Advocates🙌

WE ARE ALL #Oncoalert 🌐
Best,
@weoncologists@twitter.com

🐦🔗: https://twitter.com/OncoAlert/status/1600872263170998273

Interesting. These results suggest that there may have been resistance to the cytotoxic cargo of TDM1 (emtansine) but sensitivity to that or TDXd (deruxtecan) given same HER2 targeting vector (trastuzumab).

#oncology #radonc #DrugDevelopment

RT @Icro_Meattini@twitter.com

DESTINY-Breast02 showed statistically significant PFS and OS improvement using T-DXd for patients previously treated with T-DM1 #SABCS22 @OncoAlert@twitter.com #OncoAlert #BreastCancer

🐦🔗: https://twitter.com/Icro_Meattini/status/1600512939303354378

RT @tmprowell@twitter.com

#LetsGo #Feedalizumab!!

Our #oncology team has finished in 2nd place 2 yrs in a row. Let’s bring it home. Calling #OncoAlert @HemOncWomenDocs@twitter.com @HemOncFellows@twitter.com #advocacy & anyone touched by #cancer: donate to a food bank or #hunger org & log it for #Feedalizumab! 💪🍎👇 https://twitter.com/hcwvshunger/status/1597198630380658689

🐦🔗: https://twitter.com/tmprowell/status/1597207020733882368